US Patent Issued to Amyris on Nov. 11 for "Kaurenoic acid 13-hydroxylase (KAH) variants and uses thereof" (California Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,467,039, issued on Nov. 11, was assigned to Amyris Inc. (Emeryville, Calif.).

"Kaurenoic acid 13-hydroxylase (KAH) variants and uses thereof" was invented by Andrew P. Klein (Emeryville, Calif.), Sean Lund (Emeryville, Calif.), Gale Wichmann (Emeryville, Calif.), Irina Koryakina (Emeryville, Calif.), Kyle Hogan (Emeryville, Calif.) and Svetlana Borisova (Emeryville, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are genetically modified host cells, compositions, and methods for improved production of steviol glycosides. The host cells are genetically modified to contain a heterologous nucleic acid that expresses novel and optimize...